Reduced graphene oxide films containing stacks of rGO layers and their applications
rGO films with stacked layers address the limitations of existing neuroprosthetic devices by providing high conductivity, flexibility, and stability, improving neural interface accuracy and durability.
Patent Information
- Application Number
- JP2021549933
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-02-27
- Filing Date
- 2020-02-27
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2040-02-27
AI Technical Summary
Existing neuroprosthetic devices face challenges with electrode materials that degrade due to faradaic reactions, lack flexibility, and have limited miniaturization potential, leading to poor accuracy and durability when interfacing with neural tissue.
Development of reduced graphene oxide (rGO) films with stacked layers that offer high conductivity, flexibility, and chemical stability, enabling low interfacial impedance and high charge injection capabilities, suitable for neural interfaces.
The rGO films provide improved biocompatibility, durability, and miniaturization, allowing for high spatial resolution and reduced noise interference, enhancing the performance of neural interfaces.
Smart Images

Figure 0007579796000002 
Figure 0007579796000003 
Figure 0007579796000004
Abstract
Description
[Technical field]
[0001] This application claims the benefit of European Patent Application No. 19382146.9 filed on 27 February 2019. The project leading to this application has received funding from the Graphene Flagship Programme (GrapheneCore2) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 785219).
[0002] The present invention relates to reduced graphene oxide (rGO) films comprising a stack of rGO layers that exhibit high electrical conductivity in electrolyte-based systems. These rGO films can be incorporated into devices where high charge and fast charge injection is required, such as implantable electronic devices for neural interfacing (e.g., neurostimulator devices for deep brain electrical stimulation or peripheral nervous system stimulation, cochlear and retinal implants, pacemakers, brain-computer interfaces, etc.). [Background technology]
[0003] Neural prosthetic devices are powerful tools for monitoring, preventing and treating neurological diseases, disorders and conditions by electrically interfacing with the nervous system. When implanted in neural tissue, they can record and stimulate electrical neural activity. Currently, most neural prosthetic technologies are based on interfacing with neural tissue over electrodes.
[0004] The interface can occur via faradaic or capacitive currents. On the one hand, faradaic currents are related to redox reactions that occur at the electrode / tissue interface. These reactions will eventually degrade the electrode and damage the tissue. On the other hand, capacitive currents result from the charging and discharging of the double layer that appears when the conductor is placed in a liquid environment. For implants, capacitive currents are always preferred over faradaic currents, as they do not harm the tissue or degrade the electrode material. Thus, high capacitance is ideal to achieve an effective and safe interface with the neural tissue. Capacitance sets performance values such as the charge injection limit (CIL) of a material and its impedance. When recording and stimulating neural activity in the nervous system, a high level of charge injection and low impedance is desirable. The size of the electrode is limited by the performance of the material that composes it, and high-performance materials allow a higher level of miniaturization in terms of high capacitance.
[0005] However, the precision of the interface and the durability of the device are properties that should be improved to increase the acceptance of the technology, improve its therapeutic application, and reduce postoperative complications. The precision of the interface can be improved by decreasing the electrode size and increasing the resolution of the electrode array. Typically, electrodes exhibit limitations in miniaturization due to the intrinsic impedance and charge injection limit (CIL) of the material that composes the electrode. The durability of the device depends on the chemical stability of the electrode material, its biocompatibility, and its mechanical compliance with the living tissue.
[0006] The body's immune response to materials is another factor to consider when implanting devices in living tissue. For example, scar tissue formation and inflammation can occur around the implant area. The immune response tends to encapsulate the foreign body, which reduces the electrical performance of the device over time. Materials that have a strong stiffness mismatch with the implanted tissue are attacked more aggressively by the body. Therefore, flexible and soft materials are preferable over stiff or thick materials. Thin devices are also necessary to minimize the immune response.
[0007] The long-term stability of the material is also an important property when considering a routine implant, and materials with high chemical and mechanical stability are required.
[0008] Standard commercially available neural interfaces are based on metallic microelectrodes made of Pt, platinum-iridium (Pt / Ir), iridium oxide (IrOx) or titanium nitride (TiN). These materials interact with biological tissues via a combination of faradaic and capacitive currents, exhibit poor chemical stability and lack flexibility. Metallic performance drops significantly for microelectrodes with diameters of tens of micrometers, and moreover, metals are degraded by continuous tissue stimulation.
[0009] Recently, conducting polymers such as the polymer blend poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) have emerged as promising candidates to overcome the limitations of metal microelectrodes. However, when implanted, its interface with tissue is also via a combination of faradaic and capacitive currents. By improving the impedance and CIL of metals along with their flexibility, higher performance can be achieved in recording and stimulating neural tissue. However, delamination can occur, thereby compromising long-term stability. PEDOT:PSS is said to have problems during stimulation because it degrades chemically and mechanically during actuation.
[0010] Graphene is a material with very interesting properties for neural interfacing. It is conductive, flexible, mechanically robust, and highly inert, making it a promising candidate for safe electrical interfaces in aqueous environments. However, the performance of single-layer graphene microelectrodes is far from optimal for neural interfacing, especially in applications requiring stimulation of neural tissue. Since the impedance is limited by the capacitance of the graphene / tissue interface and stimulation is a capacitive process, three-dimensional porous graphene-based materials with large area-to-volume ratios have been proposed to overcome this issue. However, such graphene materials processed from flakes, including those made from reduced graphene oxide (rGO), have been reported to require thicknesses in the range of hundreds of micrometers to achieve effective properties in terms of stimulation. [Prior art documents] [Non-patent literature]
[0011] [Non-Patent Document 1] Hebert, et al., “Flexible Graphene Solution-Gated Field-Effect Transistors:Efficient Transducers for Micro-Electrocorticography”, Advanced Functional Materials,Vol.28(12), (2018.03) [Non-Patent Document 2] Badia, et al., “Comparative analysis of transverse intrafascicular multichannel,longitudinal intrafascicular and multipolar cuff electrodes for the selective stimulation of nerve fascicles”, J Neurl Eng, (2011.06) [Non-Patent Document 3] Taer, E. et al., “The Relationship of Surface Area to Cell Capacitance for Monolith Carbon Electrode from Biomass Materials for Supercapacitor Aplication”, Journal of Physics:Conference Series,Volume 1116,Issue 3 [Non-Patent Document 4] Hess, Lucas H. et al., “Graphene Transistors for Bioelectronics”, Proceedings of the IIEEE|Vol.101,No.7, 2013.07) Summary of the Invention [Problem to be solved by the invention]
[0012] Therefore, to overcome the problems of the prior art, there remains interest in developing high-performance thin graphene-based materials that can be easily integrated into devices and are long-lasting. [Means for solving the problem]
[0013] We have developed stable thin films of reduced graphene oxide (rGO) comprising stacks of rGO flakes that exhibit significantly increased electrochemically active surface area compared to atomic monolayers of carbon (monolayer graphene). As a result, these rGO films can provide high charge injection properties in an efficient and consistent manner during their functional lifetime. These graphene materials can be used for the fabrication of electronic devices such as microelectrodes that exhibit low interfacial impedance (Z), very high charge injection limit (CIL) and remarkable stability. These rGO films are highly porous.
[0014] The rGO membranes of the present invention are flexible and highly mechanically and chemically stable, especially in aqueous solutions, and furthermore, their production is easily scalable and compatible with high-volume manufacturing processes.
[0015] Electronic devices comprising the rGO membrane of the present invention have the advantage that they exhibit good biocompatibility when used as a neural interface and therefore can be safely used when implanted in the body. In particular, as shown in the examples, the rGO membrane of the present invention has demonstrated biocompatibility with cells encountered in a neural tissue environment. Furthermore, due to the fact that the top surface of the rGO membrane of the present invention, which is in direct contact with biological tissue, has a low roughness, the rGO membrane of the present invention does not damage the tissue, peel off, or leave undesirable residues. As a result, these implants produce minimal inflammatory (local or systemic) reactions from the neural tissue.
[0016] Moreover, due to their high electrical conductivity and charge injection capacity, devices comprising the rGO material of the present invention can be miniaturized (e.g., diameter less than about 10 μm and thickness less than about 1 μm), thereby expanding their functionality for interfacing with the nervous system, on the one hand, in areas about 1 / 25 of the current commercial technology, and on the other hand, being minimally invasive. Moreover, when it is desired to observe larger areas of the body, devices comprising the rGO films of the present invention can be arranged in the form of arrays with various densities.
[0017] Finally, as shown in the examples, devices containing the rGO material of the present invention achieve a significant improvement in signal-to-noise ratio (SNR) and a substantial reduction in electrical interference noise compared to gold electrodes. They allow the detection of neuronal ensembles and even individual neuronal signals (noise levels below about 3 μV root mean square (rms) for electrodes with a diameter of about 25 μm). They also allow the detection of neuronal ensembles over large areas (tens of cm). 2 ) and high spatial resolution (up to several hundred μm 2Furthermore, when tested in vivo in rodents, neural stimulation via intraneural implants containing the rGO membrane of the present invention was demonstrated to activate a specific subset of axons within the nerve bundle of the sciatic nerve with low current thresholds and high selectivity.
[0018] All these features (biocompatibility, durability, high performance, charge injection capability suitable for stimulation applications, minimal material footprint when implanted, small size, etc.) make them particularly interesting for use as neural interfaces.
[0019] Thus, a first aspect of the present invention relates to a reduced graphene oxide (rGO) film having a total thickness of 20 nm to 5 micrometers, comprising a stack of flake-containing rGO layers, the distance between two consecutive layers being 0.2 to 0.7 nm. In particular, said film is prepared by the following process: i) filtering a graphene oxide (GO) solution through a porous membrane, thereby forming a GO membrane on top of the membrane, in particular, the graphene oxide (GO) solution is an aqueous solution, the concentration of graphene oxide (GO) in the solution is 0.001 to 5 mg / mL, and the filtered volume is 5 to 1000 mL; ii) transferring the GO film from the membrane onto a sacrificial substrate, the GO film being disposed between the upper membrane and the lower sacrificial substrate; iii) removing the membrane, whereby the GO film remains attached to the sacrificial substrate; and iv) performing a thermal annealing step at a temperature of 100 to 240° C. for 10 5 From 4 × 10 8 hydrothermally reducing the GO film in the presence of water at a pressure of 100 Pa for a period of 1 min to 24 h to form reduced GO material (rGO); v) removing the rGO material from the sacrificial substrate; The method can be obtained by a method comprising the steps of:
[0020] To improve the capacitive properties of the rGO films of the present invention, they can be optionally attached to additional conductive materials or supports such as single layer graphene (SLG), few layer graphene or multilayer graphene (FLG, MLG) as well as other conductive substrates such as indium tin oxide, platinum or gold, metals, etc. Thus, another aspect of the present invention relates to an electrically back-contacted conductive reduced graphene oxide (rGO) structure comprising an rGO film as defined above and an additional conductive support onto which the rGO is deposited.
[0021] Another aspect of the present invention is a process for the preparation of a rGO membrane as defined above, comprising the following steps: i) filtering a graphene oxide (GO) solution through a porous membrane, thereby forming a GO membrane on top of the membrane, in particular, the graphene oxide (GO) solution is an aqueous solution, the concentration of graphene oxide (GO) in the solution is 0.001 to 5 mg / mL, and the filtered volume is 5 to 1000 mL; ii) transferring the GO film from the membrane onto a sacrificial substrate, the GO film being disposed between the upper membrane and the lower sacrificial substrate; iii) removing the film, thereby leaving the GO film attached on the sacrificial substrate; and iv) In particular, at temperatures between 100 and 240°C, 5 From 4 × 10 8 hydrothermally reducing the GO film in the presence of water at a pressure of 100 Pa for a period of 1 min to 24 h to form reduced GO material (rGO); v) removing the rGO material from the sacrificial substrate; The present invention relates to a method comprising the steps of:
[0022] Another aspect of the present invention is a process for preparing an electrically back-contacted conductive reduced graphene oxide (rGO) structure as defined above, comprising the following steps: i') filtering a graphene oxide (GO) solution through a porous membrane, thereby forming a GO membrane on top of the membrane, in particular, the graphene oxide (GO) solution is an aqueous solution, the concentration of graphene oxide (GO) in the solution is 0.001 to 5 mg / mL, and the filtered volume is 5 to 1000 mL; ii') transferring the GO film from the membrane onto an additional conductive support, the GO film being disposed between the upper membrane and the lower additional conductive support; iii') removing the film, whereby the GO film remains attached on the additional conductive support; and iv') In particular, at temperatures between 100 and 240°C, 10 5 From 4 × 10 8 hydrothermally reducing the GO film in the presence of water at a pressure of 100 Pa for a period of 1 min to 24 h to form reduced GO material (rGO); The present invention relates to a method comprising the steps of:
[0023] As mentioned above, the rGO-based membranes of the present invention, optionally attached to an additional conductive support, can be integrated into electronic devices (implantable or non-implantable) for neural interfacing. Thus, the rGO membranes of the present invention are particularly suitable for implantation in humans, and in particular for detecting, receiving and / or inducing electrical signals in humans.
[0024] Thus, a further aspect of the present invention relates to an electronic device comprising an rGO film as defined above or an electrically back-contacted conductive reduced graphene oxide (rGO) structure as defined above for detecting, receiving and / or guiding an electrical signal.
[0025] Another aspect of the present invention relates to a method for detecting, receiving and / or inducing electrical signals in a mammal, particularly a human, comprising implanting in the mammal, particularly a human, an electronic device comprising an rGO film as defined above.
[0026] Another aspect of the invention relates to a method for detecting, receiving and / or inducing electrical signals in a mammal, particularly a human, comprising implanting in the mammal, particularly a human, an electronic device comprising a reduced graphene oxide (rGO) film or an electrically back-contacted conductive reduced graphene oxide (rGO) structural material as defined above. [Brief description of the drawings]
[0027] [Figure 1] FIG. 1 shows one embodiment of the preparation method of the rGO film of the present invention, which includes (A and B) filtering a GO solution through a nitrocellulose membrane, (C) transferring a deposited film of stacked GO flakes onto a conductive substrate, and (D) hydrothermal reduction of the ensemble. [Diagram 2] FIG. 2(A) shows an SEM micrograph of a cross-section of an rGO film of the invention, and FIG. 2(B) shows an atomic force microscope (AFM) image revealing the roughness of the top surface of an rGO film of the invention.
[0028] [Diagram 3] FIG. 3(a) shows a cross-sectional view of the rGO film of the invention by HRTEM along the cross-sectional lamella of the material. The scale bar corresponds to 20 nm. FIG. 3(b) shows the profile along the discontinuity line of FIG. 3(a), where the intensity of the figure oscillates periodically every 0.4 nm. FIG. 3(c) shows the power spectrum of FIG. 3(a). Scale bar=1 / 10 nm. In FIG. 3(d), two symmetrical peaks appear at 1 / 2.7 nm, indicating the preferred orientation of the stacking of the flakes at 0.37 nm. FIG. 3(e) shows the X-ray diffraction spectrum of the GO film on the gold substrate (before hydrothermal reduction) and the HTrGO film of Example 5. The GO film shows a peak at 11° characteristic of parallel stacking of GO flakes with an interlayer distance of about 0.81 nm in the film, while in the rGO film, the peak at 11° disappears and a new peak appears at 23° characteristic of parallel stacking of GO flakes with an interlayer distance of about 0.39 nm. Figure 3(f) shows the average Raman spectra of GO and HTrGO. The ratio of the D peak to the G peak increases after hydrothermal treatment.
[0029] [Figure 4] Figure 4(a) shows the full XPS spectra of GO and HTrGO showing the C1s and O1s peaks. From their intensities, the carbon to oxygen ratio can be calculated. Figure 4(b) shows the C1s peaks of GO and HTrGO indicating a decrease in oxygen-related bonds typical of the reduction process. Figure 4(c) shows the resistivity of the GO and HTrGO films. The hydrothermal reduction of GO reduced the measured resistivity from ~67 kΩ·cm to ~0.2 Ω·cm.
[0030] [Diagram 5] Figure 5(a) shows an electron energy loss spectroscopy high angle annular dark field (HAADF) scanning transmission electron microscope (STEM) image of an EGNITE (Example 5) lamella. Figure 5(b) shows a STEM electron energy loss spectroscopy (EELS) elemental map obtained using the C k-edge at 284 eV, the O K-edge at 532 eV, and the Ti L-edge at 456 eV on a selected area from a as indicated by the white box. Figure 5(c) shows the relative atomic composition of C and O. Carbon is present at approximately 85%, while oxygen reaches 15%.
[0031] [Figure 6] FIG. 6(a) is a schematic diagram of the experimental setup for neural activity recording. A flexible array of microelectrodes was placed on the surface of the auditory cortex and a 16 kHz pure tone was presented. FIG. 6(b) shows impedance measurements at 1 kHz for an array according to the invention (EGNITE) and a Pt array. FIG. 6(c) shows a μECog device according to the invention placed on the auditory cortex. FIG. 6(d) shows evoked local field potentials with a 16 kHz pure tone and 200 ms duration (shadow) measured with a microelectrode according to the invention. A postmortem signal is superimposed. FIG. 6(e) shows the same with a Pt microelectrode. FIG. 6(f) shows the power spectral density (PSD) of the microelectrode of the invention and a Pt microelectrode in both in vivo and postmortem conditions. FIG. 6(g) shows the signal-to-noise ratio calculated from the ratio of signals between in vivo and postmortem conditions from FIG. 6(f).
[0032] [Figure 7] Figure 7 shows nerve stimulation. Figure 7(a,b) is a schematic diagram of the implantation of a transverse intrafascicular multielectrode array into the sciatic nerve via innervation of the tibialis anterior (TA), gastrocnemius (GM) and plantaris (PL). Figure 7(c) shows an optical image of the device implanted laterally through the sciatic nerve. Figure 7(d) shows a train of current-controlled stimulation and CMAPs of the TA, GM and PL muscles. Figure 7(e) shows plots of TA, GM and PL CMAP amplitudes versus stimulation intensity.
[0033] [Figure 8] Figure 8 shows CMAPs of PL, GM and TA muscles normalized to the maximum response of one microelectrode (the one with *). Fascicles closer to the microelectrode trigger responses at a lower threshold than fascicles farther away. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0034] All terms used in this application are to be understood in their ordinary meaning known in the art unless otherwise specified. Other, more specific definitions of certain terms used in this application are set forth below and are intended to be applied uniformly throughout the specification and claims.
[0035] As used herein, the term "about" or "approximately" refers to values within a range of ±10% of the specified value. For example, the phrase "about 10" or "approximately 10" includes ±10% of 10, i.e., from 9 to 11.
[0036] In the present invention, the term "graphene oxide" (GO) refers to a material that contains carbon atoms like graphene, but also contains populations or amounts of oxygen functional groups. The term "reduced graphene oxide" (rGO) refers to graphene oxide (GO) that has been reduced by a reduction process, such as a hydrothermal reduction process, resulting in a reduced oxygen content compared to the GO prior to the reduction step (i.e., non-reduced GO). The term "HTrGO" refers to hydrothermally reduced graphene oxide (GO).
[0037] The term "electrode" as used herein refers to an electrical conductor that interfaces two media, where the electrode connects the body (or tissue from the body) to a device for drawing electrical signals (e.g., to provide neural stimulation) and / or receiving electrical signals (e.g., to monitor neural activity).
[0038] The term "capacitance" refers to the ratio of the charge stored in a capacitor to a given potential difference. Capacitance is measured in Farads (F).
[0039] The term "charge storage capacity (CSC)" as used herein refers to the maximum amount of charge that a system consisting of two conductive media separated by a dielectric medium can withstand at a given potential difference. To obtain the charge storage capacity of a system, the cyclic voltammetry technique can be performed. For that, the voltage applied to it is varied cyclically and the current is measured. The accumulated charge due to the measured current corresponds to the charge storage capacity. The charge storage capacity is measured in coulombs (C).
[0040] As used herein, the term "charge injection limit (CIL)" refers to the maximum amount of charge that can be injected through an electrode into the electrolyte medium without inducing irreversible Faradaic reactions. Ideally, charge is injected only via capacitive current, avoiding reversible Faradaic reactions. The charge injection limit is expressed in mC / cm 2 It is measured in.
[0041] The term "impedance" as used herein refers to a measure of the resistance a circuit presents to an electric current when a voltage is applied. The impedance of an electric circuit can be obtained by dividing the current flowing through the electric circuit by the applied voltage signal. Impedance is measured in ohms (Ω). Depending on the behavior of the current and voltage, capacitance can be identified and matched to impedance. When referring to electrodes, impedance is referred to as interfacial impedance.
[0042] The term "resistivity" is the property of a material that quantifies its strength at resisting or conducting electric current and is measured in ohms (Ω·m). A high resistivity value indicates that the material is a poor conductor, while a low value indicates that the material is a good conductor.
[0043] The term "stability" of the rGO film as used herein is understood as the absence of an increase in interfacial impedance for at least 100 million consecutive electrical pulses.
[0044] The term "surface area to volume ratio (SAVR)" of rGO membranes is the ratio of surface area to volume, m -1 The SAVR can be measured by dividing the surface area by the volume of the rGO film. The surface area of the rGO film was determined by dividing the current of the rGO film measured at 0 V in cyclic voltammetry between -0.9 and 0.9 V at a scan rate of 50 mV / s in phosphate buffered saline (PBS) electrolyte by the specific interfacial capacitance of single-layer graphene (2-5 μF / cm 2 ) times the scan rate (50 mV / s) (see Taer, E. et al., Journal of Physics: Conference Series, Volume 1116, Issue 3, Hess, Lucas H. et al., Proceedings of the IEEE | Vol. 101, No. 7, July 2013).
[0045] The present invention relates to reduced graphene oxide (rGO) thin films comprising a stack of rGO layers that exhibit increased electrochemically active surface area compared to an atomic monolayer of carbon. Without being bound by theory, it is believed that the improved electrochemical performance is achieved due to both the stacking distance between the graphene layers of the flakes of 0.2 to 0.7 nm and the open channels that can act as ion transport shortcuts in the dense graphene stacks. The open ion transport shortcuts and the inter-stack distance are believed to be due to the preparation process of the rGO membrane of the present invention, which includes a hydrothermal reduction step in which oxygen groups are removed from the basal plane of the flakes.
[0046] The increase in electrochemically active surface area can be demonstrated by measuring the interfacial capacitance of the rGO film in aqueous solutions. In some embodiments of the present invention, the surface area is increased by 10 for a film with a thickness of 1-2 μm. 4 fold increase. This can be derived from the impedance spectroscopy data. This can also be evidenced by the lower resistivity value of the reduced rGO film compared to the higher resistivity value of the non-reduced GO film (Figure 4c).
[0047] In one embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the reduced graphene oxide (rGO) film as defined above, having a thickness of 1000 to 2000 μm (roughly corresponding to a film containing about 5000 layers of flakes) and an interlayer distance of about 0.4 nm, exhibits a thermal conductivity of 10 to 60 mF / cm in an electrolyte-based system, more particularly in an aqueous system. 2 The electrochemical surface area is such that it can provide a capacitance of 1000 .mu.m.
[0048] In one embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, the surface area to volume ratio (SAVR) of the rGO membrane as defined above, measured as defined above, is greater than or equal to 10 8 From 10 10 m -1 It is.
[0049] In a particular embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, the reduced graphene oxide (rGO) film as defined above exhibits a resistivity of 0.01 to 10, more particularly 0.05 to 5 or 0.1 to 1, and even more particularly about 0.2 Ω cm.
[0050] The structure of the rGO films of the present invention, including a stack of rGO layers containing flakes, can be characterized by various techniques, including SEM, TEM, AFM, HAADF, STEM-EELS, XRD, XPS, and Raman, as described below.
[0051] In the present invention, the term "stack" as used herein refers to a plurality, i.e. more than one, in particular 100 to 500000 layers, horizontally aligned or arranged, i.e. placed on top of each other. The layered structure can be evaluated by scanning electron microscope (SEM) images (Figure 2A). The term "flake" refers to a material having a flat and thin shape. A plurality of flakes forms a layer.
[0052] The term "stack" distance or "interstack" distance refers to the distance between two successive layers or planes of flakes or layers that are deposited one on top of the other, and can be measured by X-ray diffraction (XRD) data and high resolution transmission electron (HRTEM).
[0053] In one embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the flakes are perforated flakes. The term "perforated flakes" refers to flakes that contain two-dimensional holes in the rGO structure. The holes in the flakes can also be defined as voids, cavities, openings, or spaces. These spaces also enhance the electrochemical performance and result from the hydrothermal reduction process.
[0054] In one embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the stack of rGO layers includes from 100 to 500000, more specifically from 30000 to 100000, even more specifically from 30000 to 80000, and even more specifically from 50000 to 60000 layers of flakes. As mentioned above, the reduced graphene oxide (rGO) films of the present invention have a total film thickness of 20 nm to 5 micrometers.
[0055] In one embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the reduced graphene oxide (rGO) film has a total film thickness of 500 to 2000 nm, or 25 nm to 1 micrometer, more particularly 25 to 500 nm, and even more particularly 25 to 200 nm. This thickness provides an additional advantage in some applications, as it results in a transparent material, allowing the interface between the transparent electrode and the tissue to be observed by optical techniques.
[0056] The thickness of the rGO films of the present invention can be measured, for example, by scanning and / or transmission electron microscopy (SEM, TEM). Figure 2A shows a micrograph of a cross-section of a rGO film of one embodiment of the present invention.
[0057] In one embodiment, optionally in combination with one or more features of the various embodiments described above or below, the reduced graphene oxide (rGO) film of the present invention exhibits the X-ray photoelectron spectroscopy (XPS) spectrum shown in Figures 4a and / or 4b (see HTrGO).
[0058] In another embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the reduced graphene oxide (rGO) films of the present invention have a carbon to oxygen ratio (atomic percentage) of 0.8 to 2.0 or 1.2 to 2.0, more particularly 1.0 to 1.5 or 1.6 to 1.8, and even more particularly about 1.22. The carbon to oxygen ratio can be calculated from X-ray photoelectron spectroscopy (XPS).
[0059] As mentioned above, the stacking distance in the rGO films of the present invention is a result of the hydrothermal reduction step used to prepare the films. Thus, for example, when the stacking distance between the flakes of a particular sample before and after hydrothermal reduction was investigated by X-ray diffraction (XRD), a decrease from 0.81 ± 0.08 nm before reduction (GO) to 0.39 ± 0.06 nm after reduction (rGO) was observed (Figure 3e).
[0060] Thus, in one embodiment, optionally in combination with one or more features of the various embodiments described above or below, the reduced graphene oxide (rGO) film of the present invention has the X-ray diffraction (XRD) spectrum shown in FIG. 3e (see HTrGO).
[0061] In an embodiment, optionally in combination with one or more features of the various embodiments described above or below, the reduced graphene oxide (rGO) film of the present invention exhibits a profile along the highlight line (FIG. 3a) of the cross section of the material measured by HRTEM, as shown in FIG. 3b.
[0062] In an embodiment, optionally in combination with one or more features of the various embodiments described above or below, the reduced graphene oxide (rGO) film of the present invention exhibits a profile along the enhanced line (FIG. 3c) of the power spectrum of the cross section of the material, as shown in FIG. 3d.
[0063] In one embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the distance between two successive layers of the flake is from 0.3 to 0.5, more particularly from 0.37 to 0.43, and even more particularly about 0.4 nm, as measured by X-ray diffraction (XRD).
[0064] On the other hand, the X-ray diffraction spectrum of non-reduced GO crystalline films typically shows a peak at 11 ± 0.5, σ = 4, 2 theta degrees measured by X-ray diffractometer (XRD) with Cu Kα radiation (1.540598 Å), which is characteristic of parallel stacking of GO (non-reduced) flakes in the film. In contrast, when the GO film is reduced and has a disordered state, this peak is practically absent in the corresponding X-ray diffraction spectrum (Figure 3e). XRD measurements (theta-2 theta scan) can be performed, for example, on a Materials Research Diffractometer (MRD) from Malvern PANalytical. This diffractometer is equipped with four circular horizontal omega-2 theta goniometers (radius 320 mm) and works with a ceramic X-ray tube with a Cu Kα anode (l = 1.540598 Å). The detector used is a Pixcel, a fast X-ray detector based on Medipix2 technology.
[0065] Thus, in one embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the reduced graphene oxide (rGO) film as defined above exhibits an X-ray diffraction spectrum that is substantially absent of peaks at 11±0.5, σ=4, 2 theta degrees characteristic of non-reduced graphene oxide as measured by an X-ray diffractometer using CuKα radiation (1.540598 Å), in other words, at best, only very short range order is present in the rGO film of the present invention. As used herein, the term "substantially absent" refers to the presence of no more than about 1% area / area, more particularly no more than 0.1% area / area, of peaks corresponding to non-reduced GO crystalline films. More particularly, the reduced graphene oxide (rGO) film as defined above exhibits the X-ray diffraction spectrum shown in FIG. 3e (HTrGO).
[0066] In another embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the reduced graphene oxide (rGO) film as defined above exhibits a peak at 23±0.5, σ=4, 2 theta degrees in an X-ray diffraction spectrum measured with an X-ray diffractometer using CuKα radiation (1.540598 Å). As discussed above, the rGO film of the present invention, when implanted, produces minimal inflammatory (local or systemic) response from neural tissue. This can be at least partially explained by the fact that the top surface of the rGO film of the present invention, which is in direct contact with biological tissue, has low roughness and does not leave undesired residues. The roughness of the top surface of the rGO film can be measured by atomic force microscopy (AFM). As shown in FIG. 2B, the surface of the rGO film of one embodiment of the present invention has a surface area of 25×25 μm 2 It has been observed that the surface has a low root mean square roughness of approximately 55 nm for an area of 100 nm, which is expected to prevent tissue damage while simultaneously promoting cell attachment and proliferation while minimizing bacterial interactions.
[0067] In one embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, the top surface of the rGO film of the present invention, which is in direct contact with biological tissue when the film is implanted, has a size of 25×25 μm as measured by atomic force microscope (AFM). 2 area, has a root mean square roughness of 1 to 200, more particularly 10 to 100, and even more particularly about 55 nm.
[0068] Raman spectroscopy can also be used to characterize the reduced graphene oxide (rGO) membranes of the invention. The ratio of the intensity D to G (D / G) bands is a measure of the defects present in the graphene structure. In one embodiment, the reduced graphene oxide (rGO) membrane as defined above, optionally in conjunction with one or more features of the various embodiments above or below, is a 20×20 μm 2In the Raman spectrum for an area of 100 nm, the reduced graphene oxide (rGO) film exhibits a D to G ratio (peak amplitude / peak amplitude) of 0.9 or more, more particularly 0.9 to 2.4, even more particularly 0.9 to 1.5, and even more particularly about 1.14. More particularly, the reduced graphene oxide (rGO) film defined above has the Raman spectrum shown in FIG. 3f.
[0069] As discussed above, the reduced graphene oxide (rGO) films of the present invention exhibit high electrical conductivity in electrolyte-based systems. In one embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, the reduced graphene oxide (rGO) films of the present invention exhibit high electrical conductivity in electrolyte-based systems, more particularly aqueous systems, of 2 to 10 mC / cm when implemented on electrodes with a diameter of about 25 micrometers. 2 and an impedance of 10 to 100 kΩ at a frequency of 1 kHz.
[0070] As a result of the process used to prepare the reduced graphene oxide (rGO) films of the present invention, the elemental composition of the resulting rGO films has reduced oxygen content compared to non-reduced films. The chemical composition of the exterior and interior of the rGO films can be investigated using X-ray photoelectron spectroscopy (XPS) and electron energy loss spectroscopy (EELS). In one embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, the elemental composition of the exterior surface and its interior (bulk portion) of the rGO film is uniform (FIG. 5).
[0071] Thus, in one particular embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, the elemental composition of the rGO film consists essentially of carbon in an amount of about 80% or more of the atomic composition and oxygen in an amount of about 20% or less of the atomic composition, more specifically, carbon in an amount of about 85% or more of the atomic composition and oxygen in an amount of about 15% or less of the atomic composition, and even more specifically, carbon in an amount of about 88% or more of the atomic composition and oxygen in an amount of about 12% or less of the atomic composition.
[0072] In the present invention, the term "elemental composition consists essentially of" means that certain additional components may be present in the film, i.e., components that do not substantially affect the essential properties of reduced graphene oxide. In one embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the elemental composition of the rGO film consists of carbon and oxygen in the amounts set forth above.
[0073] As mentioned above, the present invention also relates to an electrically back-contacted conductive reduced graphene oxide (rGO) structure comprising an rGO film as defined above and an additional conductive support on which the rGO is deposited.
[0074] In the present invention, the term "back contact" as used herein means that the rGO film is placed on an additional conductive support such that the bottom surface of the rGO film is in contact with one surface of the conductive support. The additional conductive layer contributes to lowering the electrical access resistance of the rGO films of the present invention.
[0075] In one embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, the additional conductive support is selected from the group consisting of metal, single layer graphene (SLG), few layer graphene (FLG), and multilayer graphene (MLG). More particularly, the additional conductive support is single layer graphene (SLG). SLG is commercially available. Alternatively, SLG can be grown by chemical vapor deposition on copper foil, as shown in the examples.
[0076] Examples of metals that can be used as additional conductive supports include, but are not limited to, platinum, gold, iridium, tungsten, indium tin oxide, stainless steel, silver, copper, nickel, and alloys, or combinations thereof.
[0077] The specific structure of the aforementioned rGO material can be obtained by a method that includes a step of evaporating graphene oxide or a step of filtering the graphene oxide on a film followed by transfer to a support and reduction of the material.
[0078] Thus, the reduced graphene oxide material defined above also forms part of the present invention, which in particular has a thermal conductivity of 100 to 240° C. 5 From 4 × 10 8 The GO membrane can be obtained by a process comprising hydrothermally reducing the GO membrane in the presence of water at a pressure of 1000 Pa for a period of 1 min to 24 h. The present invention therefore also relates to a hydrothermally reduced GO membrane as defined above.
[0079] As mentioned above, the present invention also relates to a reduced graphene oxide material as defined in, which comprises the following steps: i) filtering a graphene oxide (GO) solution through a porous membrane, thereby forming a GO membrane on top of the membrane, in particular, the graphene oxide (GO) solution is an aqueous solution, the concentration of graphene oxide (GO) in the solution is 0.001 to 5 mg / mL, and the filtered volume is 5 to 1000 mL; ii) transferring the GO film from the membrane onto a sacrificial substrate, the GO film being disposed between the upper membrane and the lower sacrificial substrate; iii) removing the film, thereby leaving the GO film attached on the sacrificial substrate; and iv) In particular, at temperatures between 100 and 240°C, 5 From 4 × 10 8 hydrothermally reducing the GO film in the presence of water at a pressure of 100 Pa for a period of 1 min to 24 h to form reduced GO material (rGO); v) removing the rGO material from the sacrificial substrate; It is possible to obtain the composition by a method comprising the steps of:
[0080] The expression "composition obtainable by the process" of the present invention is used herein to define an rGO material by its preparation process and refers to an rGO material obtainable by the preparation process comprising steps i) to v) defined above. In the present invention, the expressions "obtainable", "obtained" and similar equivalent expressions are used interchangeably, and in each case, the expression "obtainable" encompasses the expression "obtained".
[0081] The present invention also relates to a method for the preparation of a reduced graphene oxide (rGO) membrane as defined above, comprising steps i) to v) as defined above. One embodiment of the method for the preparation of a rGO membrane of the present invention is shown in FIG.
[0082] The starting graphene oxide (GO) used in step i) of the above method is commercially available. Graphene oxide contains high density oxygen functional groups such as hydroxyl and epoxy groups on its basal plane and carboxyls on its edges. It is mainly synthesized by chemical oxidation of natural graphite, although there are some reports on alternative electrochemical oxidation.
[0083] In an embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the graphene oxide (GO) solution of step i) is an aqueous solution. More specifically, the graphene oxide (GO) solution used in step i) has a concentration of 0.001 to 5 mg / mL. Typically, the volume of the GO solution to be filtered will be 5 to 1000 mL.
[0084] In another embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the graphene oxide (GO) used in step i) has a typical carbon to oxygen ratio of 0.5 to 1.0, which can be calculated from X-ray photoelectron spectroscopy (XPS).
[0085] In another embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the starting graphene oxide (GO) used in step i) is in the form of flakes with a width of >200 nm and <20 μm, more particularly >500 nm and <20 μm, and a thickness of 0.3 to 100 nm.
[0086] In another embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the porous membrane used in step i) is made of a material selected from the group consisting of nitrocellulose.
[0087] The pores of the membrane used in step i) must be smaller than the size of the starting GO flakes. Typically, the membrane has a pore size of 0.025 μm to 200 μm.
[0088] The filtration of step i) can be carried out at a subatmospheric pressure, for example at a pressure of 1 to 100 KPa. Thus, in one embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, step i) is carried out at a pressure of 1 to 100 KPa, more particularly 1 to 10 KPa.
[0089] As a result of the filtration step i), a GO membrane is formed on the membrane. In certain embodiments, optionally in conjunction with one or more features of the various embodiments described above or below, once step i) is completed, the membrane is dried at room temperature for 2 to 10 hours.
[0090] Alternatively, the filtering step in any of the methods of the present invention may be performed by evaporating a graphene oxide (GO) solution on a substrate, specifically, where the graphene oxide (GO) solution is an aqueous solution, the concentration of graphene oxide (GO) in the solution is from 0.001 to 5 mg / mL, and the volume is from 5 to 1000 mL.
[0091] All the specific embodiments described above relating to the method of the invention for preparing rGO films or electrically back-contacted conductive reduced graphene oxide (rGO) structures, including the step of filtering a graphene oxide (GO) solution on a film, also apply to similar methods in which the step of evaporating the graphene oxide (GO) solution is carried out instead of filtering the graphene oxide (GO) solution on a film.
[0092] In a particular embodiment, optionally in conjunction with one or more features of the various embodiments above or below, after the filtration step i) and before step ii), the back side of the membrane is hydrated. More specifically, wet paper is used for that purpose. Other solvents can also be used that, like water, can dissolve GO in direct contact with the porous membrane and can pass through it without damaging or dissolving the membrane.
[0093] Depending on the amount of GO filtered, the number of layers and thickness of the film may change, resulting in greater or lesser transparency. Generally speaking, filtering a higher concentration of GO results in more layers and therefore less transparency. Films thicker than 200 nm have a light transmittance of less than about 5% of the total transmittance at wavelengths from 400 to 1160 nm.
[0094] In certain embodiments, optionally in conjunction with one or more features of the various embodiments above or below, after step i) and before step ii), the porous membrane is inverted, where the surface of the GO membrane that was originally on top becomes the bottom surface and is placed in contact with a sacrificial substrate in the next step.
[0095] As used herein, the term "sacrificial substrate" means a substrate that is used to hold the reduced graphene oxide material of the present invention and is subsequently removed to generate a substrate-free reduced graphene oxide material.
[0096] The sacrificial substrate used in step ii) can be rigid or flexible. The sacrificial substrate may or may not be conductive. Depending on the nature of the substrate, the reduced graphene oxide material of the present invention can be used as the final substrate, especially when it further comprises an additional layer of conductive material disposed at the bottom of the GO film.
[0097] In one embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the substrate used in step ii) is SiO 2 The substrate is selected from the group consisting of wafer, single layer graphene (SLG), few layer graphene (FLG), multilayer graphene (MLG), and conductive metal compounds. Non-limiting examples of conductive metal compounds that can be used as the substrate include metals such as platinum, gold, titanium, iridium, tungsten, stainless steel, silver, copper, nickel, and alloys or combinations thereof, as well as iridium oxide, silver chloride, and tin nitride. More specifically, the substrate used in step ii) is selected from the group consisting of SiO 2 Other substrates that can be used include SiO 2 The wafer includes a polymer such as polyimide or parylene C that is deposited on the wafer. The deposition technique can be spin coating or evaporation.
[0098] After the GO film is disposed on the substrate as described above, the film may be optionally irradiated with, for example, air / N from the side not in contact with the GO film towards the substrate. 2 The material can be dried by blowing on it with air / N 2 For this purpose, it is sprayed for 1 to 60 seconds.
[0099] In one particular embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the transfer of the GO film from the membrane onto a sacrificial substrate in step ii) is performed by placing the GO film attached to the membrane in contact with a sacrificial substrate, whereby the GO film is disposed between an upper membrane and a lower sacrificial substrate, and the membrane is supported by a support having a compressible force of 1-500 Kg / cm. 2 The mixture is pressed (e.g., by a roller) with a pressure of 100 .mu.m.
[0100] In step iii), the film is removed, whereby the GO film remains attached only on the sacrificial substrate. In another particular embodiment, the removal is performed by peeling off the porous film, optionally in conjunction with one or more features of the various embodiments described above or below.
[0101] Then, in step iv), the GO film on the substrate is hydrothermally reduced. The reduction is carried out in the presence of water, in particular in an autoclave. 3 etc.) or acid (HNO 3 In one particular embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, the hydrothermal reduction is carried out in the absence of any base or acid or other components other than water. Typically, the reduction is carried out at a temperature of 100 to 240° C. for 10 minutes. 5 From 4 × 10 8 Pa, more specifically 10 5 From 10 6 The reaction is carried out under a pressure of 100 Pa for a period of 1 minute to 24 hours, more particularly 1 minute to 20 hours.
[0102] Even though the reduction is carried out in the presence of water, it is advantageous for the water from the autoclave not to come into direct contact with the GO membrane in order to obtain a higher yield. Thus, in one embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, the hydrothermal reduction is carried out in a closed vessel, more specifically, in a Teflon-lined vessel inside the autoclave, so that the GO membrane does not come into direct contact with water.
[0103] In another embodiment, optionally in combination with one or more features of the various embodiments described above or below, the reduction is carried out at a temperature of from 100 to 240° C., more particularly from 100 to 150° C., and even more particularly at about 134° C.
[0104] In another embodiment, optionally in combination with one or more features of the various embodiments described above or below, 5 From 4 × 10 8 Pa, more specifically 10 5 From 106 The reduction is carried out at a pressure of from 100,000 to 300,000 Pa, and more particularly from 100,000 to 300,000 Pa.
[0105] In another embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the hydrothermal reduction is carried out for a period of 1 minute to 24 hours, more specifically 1 minute to 20 hours, even more specifically 1 to 6 hours, and even more specifically about 3 hours. Depending on the time used in this step and as a result of the extent of chemical reduction, the properties of the rGO, specifically the capacitance of the resulting reduced GO film, can be tuned.
[0106] Finally, to obtain the isolated rGO film, it is detached from the substrate by immersing the reduced GO material (rGO) in water and collecting the floating reduced GO material (rGO).
[0107] In certain embodiments, optionally in conjunction with one or more of the various embodiments above or below, the present invention also relates to a method for the preparation of a reduced graphene oxide (rGO) film as defined above, comprising the following steps: a) filtering a graphene oxide (GO) solution through a porous membrane, thereby forming a GO membrane on top of the membrane, in particular, the graphene oxide (GO) solution is an aqueous solution, the concentration of graphene oxide (GO) in the solution is 0.001 to 5 mg / mL, and the filtered volume is 5 to 1000 mL; b) drying the membrane; c) rehydrating the back side of the membrane; d) inverting the membrane; e) transferring the GO film from the membrane onto a sacrificial substrate, the GO film being disposed between the upper membrane and the lower sacrificial substrate; iii) removing the film, thereby leaving the GO film attached on the sacrificial substrate; and iv) In particular, at temperatures between 100 and 240°C, 5 From 4 × 10 8hydrothermally reducing the GO film in the presence of water at a pressure of 100 Pa for a period of 1 min to 24 h to form reduced GO material (rGO); v) removing the rGO material from the sacrificial substrate; and Includes.
[0108] To prepare a reduced graphene oxide (rGO) material with an additional conductive layer forming an electrically back-contacted conductive rGO structure as defined above, a method similar to that described above including steps i) to iv) can be used, with the proviso that an additional conductive layer is used instead of a sacrificial substrate, in which case it is not necessary to carry out step v) (removal of the substrate to separate the rGO material).
[0109] Thus, in one embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, an electrically back-contacting conductive reduced graphene oxide (rGO) structure as defined above is prepared by the following process: i') filtering a graphene oxide (GO) solution through a porous membrane, thereby forming a GO membrane on top of the membrane, in particular, the graphene oxide (GO) solution is an aqueous solution, the concentration of graphene oxide (GO) in the solution is 0.001 to 5 mg / mL, and the filtered volume is 5 to 1000 mL; ii') transferring the GO film from the membrane onto an additional conductive support, the GO film being disposed between the upper membrane and a lower additional conductive layer; iii') removing the film, whereby the GO film remains attached on the additional conductive support; and iv') In particular, at temperatures between 100 and 240°C, 10 5 From 4 × 10 8 hydrothermally reducing the GO film in the presence of water at a pressure of 100 Pa for a period of 1 min to 24 h to form reduced GO material (rGO); The method is obtained by a method comprising the steps of:
[0110] Alternatively, rGO material with an additional conductive layer can be prepared by either attaching the graphene material to the additional conductive layer after the above method including steps i) to v) or by transferring the graphene material to the additional conductive layer after the above method including steps i) to iv) and removing the sacrificial substrate.
[0111] Certain embodiments described above relating to the preparation of rGO films also apply to the preparation of electrically back-contacted conductive reduced graphene oxide (rGO) structures.
[0112] In certain embodiments, optionally in conjunction with one or more features of the various embodiments described above or below, electrically back-contacted conductive reduced graphene oxide (rGO) structures are electrically activated in an electrolyte system, more particularly in an aqueous environment. This activation involves placing the material in an electrolyte and sending an electrical signal across the material / electrolyte interface. This has the advantage of improving electrical conductivity and interfacial capacitance while lowering the interfacial impedance. Typically, this method achieves a thermal conductivity of 10 mC / cm depending on the thickness of the rGO film. 2 Up to 100 µm can be injected without irreversible damage to the electrode.
[0113] As mentioned above, reduced graphene oxide (rGO) materials with high charge injection properties can be used in the fabrication of electronic devices, more particularly implantable devices such as microelectrodes. Thus, electronic devices for detecting, receiving and / or extracting electrical signals comprising reduced graphene oxide (rGO) films or electrically back-contacted conductive reduced graphene oxide (rGO) structures also form part of the present invention.
[0114] In an embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, the electronic device as defined above is a neural electrode, more particularly a microelectrode, more particularly the microelectrode is circular and has a diameter of 1 to 300 micrometers.
[0115] Examples of electronic devices (implanted and non-implanted) that can be used as neural interfaces include, but are not limited to, cortical electrodes (used for intraoperative brain mapping), retinal implants (used to improve vision), spinal cord stimulation devices (used for chronic pain), deep brain stimulation (DBS) implants (used for Parkinson's disease), cochlear implants (used to improve hearing), vagus nerve stimulation devices (VNS) (used for epilepsy), sacral nerve stimulation devices (used for neuromodulation for incontinence), and the like.
[0116] In one embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the electronic device as defined above comprises a flexible substrate patterned with conductive leads, e.g. metals such as Au, Pt or other conductors such as indium tin oxide, on which an rGO film or electrically conductive rGO-based material with back contact is deposited, and an encapsulation (also called passivation layer or insulating layer) with an opening on top, which covers the conductive leads and leaves the graphene electrode layer exposed.
[0117] In the present invention, the term "flexible" refers to the ability of a device to bend without breaking or cracking. In one embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the flexible substrate is made of polyimide or Parylene C.
[0118] In another embodiment, optionally in conjunction with one or more features of the various embodiments above or below, the encapsulation layer is made of polyimide, Parylene C or SU8 (e.g., SU-8 2000, Microchem), which is a high-contrast epoxy-based photoresist designed for micromachining and other microelectronic applications.
[0119] The electronic device as defined above may have different shapes, i.e., a suitable shape can be selected for each specific application. In one embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, the embedded electronic device as defined above has a circular, hexagonal or annular cross section.
[0120] In a particular embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, the electronic device as defined above has a thickness of between 10 and 30 μm.
[0121] The plurality of electrodes may be formed into an electrode array. Thus, in another embodiment, optionally in conjunction with one or more features of the various embodiments described above or below, the electronic device as defined above is an array of microelectrodes. The array may typically include 4 to 256 microelectrodes, more particularly circular microelectrodes having a diameter in the range of 5 to 100 micrometers. The microelectrodes may typically be spaced apart with an interelectrode distance that may range from 10 to 300 micrometers.
[0122] Electronic devices can be fabricated by a method comprising the following steps: defining a metal substrate, optionally depositing SLG onto the metal (optional), transferring additional conductive layers, preparing a GO film and transferring (upside down) as described above, defining graphene-containing microelectrodes, and passivating and hydrothermally reducing the GO film embedded in the device as previously disclosed.
[0123] In one embodiment, the electronic device comprises the steps of: a) Using standard optical lithography techniques, a first substrate (SiO 2 patterning a substrate (e.g., a wafer) to open a desired pattern, e.g., a circular pattern of about 25 micrometers in diameter in the photoresist; b) depositing a layer of chromium, titanium and / or gold on the first substrate of step a); c) removing the photoresist, for example by immersing the wafer in acetone and then in isopropanol; d) blow drying the first substrate of step c); e) optionally transferring an additional conductive layer, as defined above, e.g. SLG, onto the first substrate of step d); f) filtering the graphene oxide (GO) solution through the porous membrane, thereby forming a GO membrane on top of the porous membrane, in particular, the graphene oxide (GO) solution is an aqueous solution, the concentration of graphene oxide (GO) in the solution is 0.001 to 5 mg / mL, and the filtered volume is 5 to 1000 mL; g) transferring the GO film from the membrane onto the conductive layer of step e), the GO film being disposed between the upper porous membrane and the lower conductive layer; h) removing the film, thereby leaving the GO film attached on the conductive layer; and i) defining the area of a graphene-containing microelectrode using a combination of photolithography and reactive ion etching; j) spin-coating a passivation layer, e.g., a polyimide layer, and curing it to electrically isolate the metal contacts; k) patterning and opening the microelectrode areas using photolithographic reactive ion etching through the passivation layer; l) The microelectrode of step k) is heated, in particular at a temperature of 100 to 240° C. for 10 5 From 4 × 10 8 and hydrothermally reducing the mixture in the presence of water at a pressure of 1 Pa for a period of 1 minute to 24 hours. The composition can be produced by a method comprising the steps of:
[0124] The specific embodiments described above relating to the method for preparing an amorphous rGO film also apply to the method for preparing an electronic device.
[0125] Throughout the specification and claims, the word "comprises" and variations of this word are not intended to exclude other technical features, additives, components or steps. Furthermore, the word "comprises" encompasses the case of "consisting of". Additional objects, advantages and features of the present invention will become apparent to those skilled in the art upon examination of the specification or may be learned by practice of the present invention. The following examples and figures are provided by way of illustration and are not intended to limit the present invention. Furthermore, all possible combinations of the specific preferred embodiments described herein are within the scope of the present invention. EXAMPLES
[0126] Morphological and chemical characterization of the membranes of the present invention The base substrate for all characterization tests of the films of the present invention was Si / SiO 2 (400μm / 1μm) square (1×1cm 2 ) was.
[0127] XPS XPS measurements were performed using a monochromatic aluminum Kα X-ray source (1486.74 eV) under ultra-high vacuum conditions (base pressure 5 × 10 -8 The measurements were performed at 1000 nm (2000 Å) and 1000 nm (3000 Å) with a Phoibos 150 analyzer (SPECS GmbH, Berlin, Germany). Overview spectra were acquired with a pass energy of 50 eV and a step size of 1 eV, and high-resolution spectra were acquired with a pass energy of 20 eV and a step size of 0.05 eV. The overall resolution in these last conditions is 0.58 eV, as determined by measuring the half-width of the Ag 3d5 / 2 peak of the sputtered silver.
[0128] XRD XRD measurements (θ-2θ scans) were performed on a Materials Research Diffractometer (MRD) from Malvern PANalytical, which has four circular horizontal omega-2 theta goniometers (radius 320 mm) and a Cu K αIt was operated with a ceramic X-ray tube with an anode (λ = 1.540598 Å). The detector used was a Pixcel, a fast X-ray detector based on Medipix2 technology.
[0129] TEM For cross-sectional examination of EGNITE samples, FIB lamellae were prepared with a Helios NanoLab DualBeam (LMA-INA, Zaragoza). Structural analysis was performed by transmission electron microscopy using a TECNAI F20 TEM operated at 200 kV, including HRTEM and HAADF-STEM techniques.
[0130] STEM-EELS STEM-EELS experiments were performed on a Tecnai F20 microscope operating at 200 KeV with a 5 mm aperture, a 30 mm camera length, a convergence angle of 12.7 mrad and a collection angle of 87.6 mrad. The expected Si k-edge at 1839 eV, the Pt M-edge at 2122 eV and the Au M-edge at 2206 eV were not acquired because 0.5 eV / px and 250 eV were used as the starting energy for the core loss acquisition. The relative CO atomic composition was obtained by focusing on the GO layer and assuming that the sum of the analyzed edges (C and O in this case) is 100%. This assumption is valid in our case as evidenced by the SI maps. The energy differential cross sections were calculated using the Hartree-Slater model and the background was calculated using the low power model.
[0131] Example 1 -SiO 2 Hydrothermally reduced graphene oxide film (HTrGO) Hydrothermally reduced graphene oxide film is synthesized in the following three steps. Step 1: Filtration 20 mL of 0.15 mg / mL aqueous graphene oxide (GO) solution (using N002-PS-1.0 graphene oxide solution, Angstron Materials, this GO typically exhibits a C / O ratio of 0.5 to 1.0) was filtered through a nitrocellulose membrane with 25 nm pores (VSWP04700, MF-Millipore™ membrane filter, hydrophilic, 0.025 μm, 47 mm, white, plain). Nominally, the GO solution contained flakes 554 nm wide (average xy lateral dimensions) and 1-1.2 nm thick (average z-directional dimension). A 1500 nm thick GO membrane was placed on top of the membrane for filtration. The filtration process uses a pump capable of generating a vacuum of 10 KPa.
[0132] Step 2: Transfer Then, the back of the nitrocellulose membrane is 2 The membrane was then rehydrated using 1 ml of diethyl ether per 1000 μm of GO membrane sandwiched between two SiO 2 The film was placed against a wafer (MicroChemicals GmbH). Nitrogen was blown from the film side for 30 seconds to separate the film-GO film-SiO 2 20kg / cm 2 After this step, the film was pressed by applying a pressure of 1000 V for at least 1 second. 2 When peeled off from the SiO 2 It remained attached on the wafer.
[0133] Step 3: Reduction Then, the SiO with GO film 2 The wafer was placed in an autoclave and hydrothermally reduced at 135° C. for 3 hours.
[0134] The membrane prepared as above exhibited the following properties: Reduced GO as shown by -XPS (Figures 4a and 4b)
[0135] Example 2 - Hydrothermally reduced graphene oxide film (HTrGO) with additional conductive support (single layer graphene) Single layer graphene (SLG) was grown by chemical vapor deposition on copper foil (Alfa Aesar Coated). The copper foil was placed in a flat quartz tube (length: 1600 mm, inner diameter: 60 mm) heated by a three-zone oven. An initial annealing step at 1015°C under 400 sccm argon flow at 10000 Pa (10 KPa) for 1 h was followed by a growth step at 1200 Pa (1.2 KPa) for 15 min under a gas mixture of 1000 sccm argon, 200 sccm hydrogen and 2 sccm methane.
[0136] Graphene was synthesized from copper foil to SiO using a wet chemical method. 2 The graphene / copper foil was then transferred to a substrate. First, poly(methyl methacrylate) PMMA A2 (MicroChem) was deposited on the graphene / copper foil and allowed to dry for 12 hours. The backside graphene was then etched. To achieve this, FeCl 3 The sample was placed on the surface of an etchant solution composed of SiO2 / HCl (0.5M / 2M) for 2 min. The back side of the sample was then rinsed with water. The sample was left on the etchant for at least 6 h to remove the copper. The sample was then washed several times in water and SiO 2 The wafer was dried on a hot plate at 40° C. for 30 min and then gradually annealed in a vacuum oven to 180° C. Finally, the PMMA was dissolved in acetone and isopropanol.
[0137] The GO film was prepared and transferred as described in steps 1 and 2 of Example 1 and then deposited on SiO 2 The wafer was prepared by subjecting the wafer to the SLG / SiO 2 The transfer method used is that described in Hebert et al., Advanced Functional Materials, Vol. 28 (March 2018). Finally, the GO / SLG / SiO 2 The wafer was placed in an autoclave and hydrothermally reduced at 135° C. for 3 hours.
[0138] The structural characteristics of HTrGO were similar to Example 1, except in this case the GO film was disposed on a conductive transparent layer (SLG).
[0139] Example 3 - Microelectrodes based on HTrGO / SLG stack (EGNITE) Single layer graphene (SLG) was grown as described in Example 2. Metal microelectrodes are prepared as follows: 2 The microelectrodes were then defined on the wafer. First, the wafer was patterned with photoresist (AZ5214 MichroChemicals GmbH) using standard photolithography methods, resulting in circular patterns with a diameter of 25 micrometers being opened in the photoresist. A layer of chromium (10 nm) / gold (200 nm) was then evaporated onto the wafer. The photoresist was then removed by immersing the wafer in acetone and then in isopropanol, and finally the wafer was blown dry. The SLG was then transferred onto the wafer with microelectrodes as described in Example 2. The filtered GO film was transferred onto the SLG as described in steps 1 and 2 of Example 1, where SiO 2 The wafer was prepared using the SLG / SiO 2 The graphene-containing microelectrode was replaced by a stack of graphene-containing electrodes, where the area of the graphene-containing microelectrodes was defined by using a combination of photolithography and reactive ion etching. A passivating layer of polyimide PI 2611 (HD MicroSystems) was then spin-coated and cured to electrically isolate the metal contacts. The microelectrode area was then patterned by photolithography and opened by reactive ion etching through the polyimide.
[0140] Finally, the wafer containing GO / SLG / metal microelectrodes was placed in an autoclave and hydrothermally reduced at 135 °C for 3 h.
[0141] The electrochemical properties of the 25 micrometer diameter electrode were characterized in 0.5 M phosphate buffered saline (PBS) with an SP-200 Bio-Logic potentiostat using a three-electrode configuration: the working electrode was connected to the graphene microelectrode, the counter electrode was a large platinum wire, and the reference electrode was Ag / AgCl.
[0142] Cyclic voltammetry characterization (-0.9 to +0.9 V) revealed quasi-ideal capacitive behavior with a wide potential window of 1.8 V. These measurements showed that the capacitance of the 50 mF / cm 2 of capacitance (normalized by the geometric area of an electrode with a diameter of 25 micrometers) and 40 mC / cm 2 The charge storage capacity (CSC) of 2×10 was obtained. The surface area to volume ratio (SAVR) of 2×10 9 m -1 It is.
[0143] To investigate the charge injection limit, a current pulse experiment (pulse width 1 ms) was injected into the microelectrode. This measurement showed that a charge injection limit of 8 mC / cm was not exceeded without exceeding the safety limit of the potential window. 2 It has been proven that it is possible to inject a charge injection limit of
[0144] Electrochemical impedance spectroscopy of the microelectrodes revealed an impedance of 20 kΩ at a frequency of 1 kHz.
[0145] Example 4 - Flexible microelectrode array based on HTrGO / SLG stack Arranged in an 8x8 matrix, 1.44 mm 2 An array of 64 microelectrodes was prepared covering a total area of 100 μm. The microelectrodes had a diameter of 25 μm and were spaced 300 μm apart from each other.
[0146] First, a 10 μm thick layer of polyimide (PI, PI 2611 HD Microsystems) is deposited on SiO 2The substrate was then spun onto a wafer and cured. Gold leads (composed of a bilayer of Ti and Au, 10 nm Ti and 200 nm Au) were patterned onto this substrate PI layer using optical lithography and electron beam metal deposition. This was followed by transferring the SLG and GO films and patterning them by photolithography and reactive ion etching. Any leakage of the leads was then prevented by a passivation layer of PI with openings over the microelectrodes. The edges of the device were then patterned by cutting the PI substrate and passivation layer using a combination of optical lithography and reactive ion etching. Finally, the device was sealed on SiO 2 The wafer was peeled off, placed in a sterilization pouch, and autoclaved at 135° C. for 3 hours.
[0147] The electrochemical properties (charge storage capacity, charge injection limit, and impedance) of the microelectrodes in the flexible array are the same as those reported in Example 3 for the individual microelectrodes fabricated.
[0148] Example 5 - Flexible microelectrode array based on HTrGO with additional conductive support (gold) (EGNITE) The device is 4-inch Si / SiO 2 The GaN-based ... Prepare and transfer the GO film as described in steps 1 and 2 of Example 1 onto a SiO 2The wafer was replaced with gold polyimide silicon oxide, and then the GO film was structured using a 100 nm thick aluminum mask. Specifically, aluminum columns were e-beam evaporated and defined above the future microelectrodes by lift-off using a negative photoresist (nLOF 2070, Microchemicals GmbH, Germany). The GO film was then etched everywhere except for the future microelectrodes using oxygen reactive ion etching (RIE) for 5 min at 500 W. The protective Al columns were then etched with a dilute solution of phosphoric and nitric acids. The GO film obtained in this step was completely resting on the conductor substrate. Afterwards, a 3 μm thick layer of PI-2611 was deposited on the wafer and baked as before. The PI-2611 openings above the microelectrodes were then defined using a positive thick photoresist (AZ9260, Microchemicals GmbH, Germany) that served as a mask for the subsequent oxygen RIE. The devices were then patterned on the PI layer, again using AZ9260 photoresist and RIE. The photoresist layer was then removed in acetone, the wafer was washed in isopropyl alcohol and dried, and the device was finally peeled off the wafer, placed in a sterilization pouch, and hydrothermally reduced in a standard autoclave at 134 °C for 3 h.
[0149] The membrane prepared as described above exhibited the following properties: - A film with a total thickness of about 1500 nm containing a stack of rGO layers (see Figure 2A). -25×25μm 2 Root mean square roughness of about 55 nm for an area of 100 mm (Figure 2B) - Interstack distance of about 0.4 nm as revealed by HRTEM (Fig. 3a-d) and XRD (Fig. 3e). -D to G ratio in Raman spectrum is 20×20μm 2 The area of the carbon nanotube was 1.14, indicating a defective carbon material (see Figure 3f). - resistivity of about 0.2 Ω·cm (Figure 4c) The bulk elemental composition of the film estimated from EELS-EDX was >85% carbon and <15% oxygen (Figure 5).
[0150] Example 6 - In vivo recording of cortical activity in rodents In this section, we demonstrate the suitability of the microelectrode array of Example 4 for recording in vivo neural activity with low noise by placing a flexible microelectrocorticography (μECoG) device comprising an array of microelectrodes according to the invention on the surface of the auditory cortex while presenting auditory stimuli to record neurophysiological activity in the region ( FIG. 6( a)).
[0151] Design of the devices used Two flexible microelectrocorticography devices were used: one based on the array of the invention (called EGNITE) and the other based on platinum (Pt). Both devices consisted of a flexible array of 64 microelectrodes. The diameter of the microelectrodes of the invention was 25 μm and the diameter of the Pt electrodes was 60 μm. The spacing between the microelectrodes was 300 μm for the array of the invention and 500 μm for the Pt array.
[0152] Fabrication of the Devices Used The devices according to the invention were fabricated as described in Example 4. The Pt-based devices were obtained commercially (E64-500-20-60, NeuroNexus, USA).
[0153] Characterization of the Devices Used Before starting the experiments, the impedance of both arrays was measured at 1 kHz: for the device according to the invention a median impedance of 55±15 kΩ was obtained, whereas for the Pt array it was 650±200 kΩ (FIG. 6b).
[0154] In vivo neurorecording setup and protocol A microelectrocorticography (μECoG) device was then simultaneously placed over the rodent's auditory neocortex (device according to the invention in FIG. 6(c)) and presented with an 8 kHz pure tone. Neurophysiological signals were amplified, multiplexed, digitized, and high-pass filtered at 0.1 Hz.
[0155] In vivo neural recording results Figures 6(d) and 6e show the signals recorded by the device according to the invention and the Pt device, respectively. In both of these, evoked local field potentials (LFPs) could be detected reaching an amplitude of about 500 μV relative to the baseline about 30 ms after the onset of the audio signal. Only the microelectrode according to the invention recorded an LFP at the offset of the audio signal, probably due to its localization in the auditory cortex. The intrinsic noise of the electrodes under postmortem conditions is shown superimposed on the evoked LFPs in Figures 6(d) and (e), respectively, for the device according to the invention and for Pt. For the device according to the invention, the peak-to-peak amplitude was 12 μV, whereas Pt reached 15 μV.
[0156] The recording capabilities of the device according to the invention can be further verified and compared to Pt by observing the power spectral density (PSD) from the in vivo and postmortem signals (FIG. 6(f)). Analysis of the postmortem data gave an rms noise of 2.9 μV for the device according to the invention compared to 3.2 μV for Pt when the PSD was integrated between 10 Hz and 10 kHz. PSD testing of the in vivo data showed that the microelectrode according to the invention is able to capture more neurophysiological data than the Pt electrode from 20 Hz to 10 kHz. This phenomenon can also be observed in FIG. 6(g), where the signal-to-noise ratio (SNR) was calculated using the in vivo and postmortem signals. There, due to the lower intrinsic noise of the microelectrode according to the invention relative to Pt, the SNR of the device according to the invention exceeds Pt by an order of magnitude from 2 Hz to 2 kHz and reaches 5 times in the range of 2-8 kHz.
[0157] Example 7 - In vivo neuronal activity stimulation in rats In this section, we present the suitability of the microelectrodes according to the invention for use in implantable neuroprosthetic devices for selective nerve stimulation. To this end, the microelectrode array of Example 4 was fabricated and implanted laterally into the sciatic nerve of a rat in an acute experiment. The device selectively stimulated axon subsets of different nerve bundles within the nerve, while the activation of the plantaris (PL), gastrocnemius (GM) and tibialis anterior (TA) muscles was recorded by electromyographic (EMG) signals (Figure 7(a)).
[0158] Design of the device used The implant consisted of a long flexible foldable stripe with 18 microelectrodes, each with a diameter of 25 μm, according to the invention on its upper surface. The stripe was divided into two arrays of 9 of 18 microelectrodes, folded in a V-shape, each facing one side of the stripe. In this way, the two arrays each span a total length of 1.2 mm, a length similar to the diameter of the sciatic nerve in a rat.
[0159] Preparation of the Device Used The device was prepared as described in Example 4.
[0160] Characterization of the Device Used Prior to commencing implantation, the microelectrodes were characterized to demonstrate that they were suitable to reliably inject 8 mC / cm2 at biphasic pulses of 400 μA and 100 μs / phase duration, with a mean impedance of 55 ± 15 kΩ.
[0161] In vivo nerve stimulation setup and protocol The device was then implanted within the fascicles of the sciatic nerve of anesthetized rats, with two arrays of nine microelectrodes crossing the fascicles or subfascicles innervating the PL, GM, and TA muscles (Figure 7(b,c)). Electrical stimuli were then injected into the nerve through each microelectrode, and the amplitude of the compound muscle action potential (CMAP) retrieved in each of the three muscles was monitored through monopolar needles inserted into the GM, PL, and TA muscle bellies. The measured amplitudes were normalized to the maximum CMAP amplitude previously obtained by external stimulation at maximum intensity using a stainless steel needle electrode in the sciatic nerve. Stimulation consisted of a train of 100 biphasic pulses with increasing current amplitudes ranging from 0 to 100 μA relative to an external reference electrode placed proximal to the nerve.
[0162] Results of in vivo nerve stimulation All three muscles, PL, GM and TA, showed contractions as a result of the evoked stimulation (Figure 7(d,e)). The delay between the stimulation and the muscle response was about 20 ms due to the signal transmission time along the nerve. The muscle response increased with the amplitude of the injected current and occurred only above a certain threshold. Injecting currents continuously higher than the threshold eventually saturates the muscle contraction (Figure 6). Achieving a low threshold is very important to minimize possible damage to the tissue. Comparing the thresholds obtained with the device according to the invention with the literature (Table 1), it occurs that the stimulation performed with the microelectrodes according to the invention (EGNITE) can lower in all cases both the previously reported minimum activation thresholds for 5% and 95% by a factor of 2 to 3.
[0163] [Table 1]
[0164] Example 8 - Biocompatibility testing Protein adsorption to the substrate Heat-inactivated fetal bovine serum (FBS, Sigma-Aldrich, Merck Sigma, UK) was drop-cast (150 μL) onto four repeats of different substrates (i.e., EGNITE in Example 5; poly(3,4-ethylenedioxythiophene) polystyrene sulfonate, PEDOT:PSS, hereafter referred to as PEDOT, or tissue culture polystyrene, TCPS). After 4 h of incubation at room temperature, excess FBS was aspirated and the substrates were washed twice with PBS (Sigma-Aldrich, Merck Sigma, UK) to remove non-adsorbed proteins. Samples were then incubated with 1% sodium dodecyl sulfate (Sigma-Aldrich, Merck Sigma, UK) in distilled water (Millipore, Merck, UK) for 30 min at room temperature to desorb the adsorbed proteins. Total protein content was quantified using the Pierce BCA Assay Kit (Thermo Fisher Scientific, UK) and a spectrophotometric plate reader (Fluostar Omega, BMG Labtech, UK) operating at 562 nm for absorbance measurements, following the manufacturer's instructions. The results obtained predict no significant differences between EGNITE and TCPS (reference tissue culture polystyrene) in the ability of cells to attach and grow on the substrate.
[0165] Neuronal cell cultures Human neuroblastoma cells (SH-SY5Y (ATCC® CRL-2266™), LGC Standards, UK) were maintained in DMEM, i.e. F12 cell culture medium (Sigma-Aldrich, Merck Sigma, UK) supplemented with 20 mM glutamine (Sigma-Aldrich, Merck Sigma, UK), 10% FBS (Gibco, Thermo Fisher Scientific, UK), 1000 units penicillin and 1 mg / mL streptomycin (Sigma-Aldrich, Merck Sigma, UK) at 37° C. in a humidified 5% CO2 incubator (NuAire, USA). Cells were passaged twice a week when they reached 80% confluence using 0.05% trypsin EDTA solution (Sigma-Aldrich, Merck Sigma, UK). All experiments were performed using cells with a passage number less than 20.
[0166] Cell viability assay SHSY5Y cells were seeded at 50000 cells per substrate (i.e. EGNITE, PEDOT, TCP from Example 5) in 12-well plates (final volume 1 mL, Corning, USA). A positive control for cell death was established by adding 10% DMSO to the medium of cells grown on TCPS wells. After 24 h of cell growth on the different substrates, a sterile filtered resazurin solution obtained by dissolving resazurin sodium salt (Sigma-Aldrich, Merck Sigma, UK) in PBS to 0.15 mg.mL-1 (10x solution) was added to each well to make a 10-fold dilution. After 2 h of incubation at 37°C, 150 μL of cell culture supernatant was transferred to a black 96-well plate (Greiner Bio-one, Germany), the remaining medium was aspirated, the cells were washed with PBS, fresh complete cell culture medium was added and the cells were incubated at 37°C for the next time. The fluorescence generated from the 96-well plates was measured using a Fluostar Omega plate reader (BMG Labtech, UK) at an excitation wavelength of 560 nm and an emission wavelength of 590 nm. Fluorescence values were normalized to the mean fluorescence of the TCPS samples. After 48 hours of cell growth on the different substrates, the same procedure was performed. Cell counting was performed (trypan blue assay) using the remaining cells at 48 hours.
[0167] Cell counting assay SHSY5Y cells were seeded at 50000 cells per substrate (i.e. EGNITE, PEDOT, TCP from Example 5) in 12-well plates (final volume 1 mL, Corning, USA). Cells grown on TCPS substrates supplemented with 10% DMSO were used as a positive control for this assay. After 48 h of cell growth, the supernatant was discarded and the cells were washed twice with PBS (Sigma-Aldrich, Merck Sigma, UK) before applying a solution of trypsin-EDTA (0.05%, Sigma-Aldrich, Merck Sigma, UK) to detach the cells. An aliquot of the cell suspension was then mixed 1:1 with a sterile solution of trypan blue (0.4%, Thermo Fisher Scientific, UK) before cell counting was performed using a hemocytometer (modified BRAND counting chamber BLAUBRAND Neubauer).
[0168] Cytotoxicity assay SHSY5Y cells were seeded at 50000 cells per substrate (i.e., EGNITE, PEDOT, or TCPS from Example 5) in 12-well plates (i.e., 1 mL final volume). Cells grown on TCPS substrates supplemented with 10% DMSO were used as a positive control for this assay. To assess cytotoxicity, a modified version of the lactate dehydrogenase (LDH) assay was performed (CytoTox 96 non-radioactive cytotoxicity assay, Promega LDH assay kit). Briefly, the supernatant medium was aspirated and the cells were washed twice with PBS. The live cells at the bottom of the wells were then lysed with 200 μL lysis solution (0.9% Triton X in water (Sigma Aldrich)) for 45 min at 37 °C. The cell lysate (50 μL) was mixed 1:1 with the LDH reaction solution. The mixture was incubated at room temperature for 15-20 min until a stable red color appeared, after which 50 μL of stop solution was added to each well. The absorbance of the wells was then measured at 490 nm using a Fluostar Omega plate reader (BMG Labtech, UK). Absorbance values were expressed relative to the TCPS control.
[0169] The above experiments showed that after 48 h of culture on EGNITE membrane, viability and cell proliferation were increased compared to TCPS.
[0170] Primary hippocampal neuron growth in EGNITE Primary neuronal cell cultures were prepared from hippocampi extracted from 3-day-old neonatal rat brains (REF Pacific). Following ethical approval from the UK Home Office, neonatal animals were sacrificed under project license number P089E2E0A in accordance with the UK Animals (Scientific Procedures) Act 1986 and the ARRIVE guidelines. After determining the number of viable cells, for the first 3 days, cells were seeded on either glass coverslips or EGNITE of Example 5 (both pre-coated with 50 μg / mL poly-L-lysine) at a density of 40,000 cells per substrate in serum-free neurobasal medium (Gibco, Thermo Fisher Scientific, UK) containing B27 supplement (Gibco, Thermo Fisher Scientific, UK), 1000 units penicillin and 1 mg / mL streptomycin (Sigma-Aldrich, Merck Sigma, UK), and 0.5 mM glutamine (Sigma-Aldrich, Merck Sigma, UK). Cultures were maintained at 37°C in a humidified 5% CO2 incubator (NuAire, USA) for 14 days, with half of the well volume changed every 3 days.
[0171] Immunostaining of cells After culture, both SHSY5Y and primary neurons were washed three times with PBS (Sigma-Aldrich, Merck Sigma, UK) before being fixed with 4% PFA in PBS (Sigma-Aldrich, Merck Sigma, UK) for 10 min at room temperature. Fixed cells were then permeabilized with 0.1% Triton X (Sigma-Aldrich, Merck Sigma, UK) diluted in PBS for 5 min before being blocked with a 5% solution of goat serum in PBS (Sigma-Aldrich, Merck Sigma, UK) for 1 h. Cells were then incubated with a solution of primary antibody (β-III tubulin, ABCAM ab1827, rabbit, used at 1:200) for 2 h at room temperature. After incubation with the primary antibody, cells were washed three times with PBS before being incubated with secondary antibody (anti-rabbit conjugated with CY3, Jackson 111-165-144, used at 1:100) for 1 h at room temperature. After staining, cells were washed thoroughly and then coverslipped with Prolong Gold Antifade mountant containing DAPI (Invitrogen, Thermo Fisher Scientific, UK). Cells were observed to be more proliferative, healthier and more numerous on EGNITE compared to PEDOT:PSS or TCPS.
[0172] Microscopic imaging of β-III tubulin immunoreactivity Confocal laser scanning microscopy was performed on a Zeiss LSM 880 (Systems Microscopy Centre, Manchester Bioimaging Facility, Faculty of Biology, Medicine and Health, the University of Manchester). Images were captured using a 1 AU pinhole and 2% laser power. Post-hoc image processing was performed using the Zeiss ZEN software package. Images shown are maximum intensity projections of 10 confocal slices, scale bar 100 μm.
[0173] The results showed that after 14 days in culture, neurons grown on EGNITE formed a network of well-individualized branching neurons, whereas neurons grown on glass coverslips tended to aggregate and their extensions became bundled.
[0174] statistical analysis The Mann-Whitney U test using Graphpad Prism software was applied for all in vitro cell culture assays. For all experiments, p values were indicated as follows: (*) p<0.05, (**) p<0.01, (***) p<0.005, (****) p<0.0001.
Claims
1. A reduced graphene oxide (rGO) film having a total thickness of 20 nm to 5 micrometers, comprising a stack of reduced graphene oxide (rGO) layers containing flakes, the distance between two successive layers being 0.2 to 0.7 nm, and the stack of rGO layers comprising 100 to 500,000 layers of flakes. Reduced graphene oxide (rGO) film.
2. 2. The reduced graphene oxide (rGO) film of claim 1, wherein the distance between two consecutive layers is 0.3 to 0.5 nm.
3. 3. The reduced graphene oxide (rGO) film of claim 1, wherein the total film thickness is from 500 to 2000 nm.
4. 4. The reduced graphene oxide (rGO) film of claim 1, wherein the stack of rGO layers comprises between 30,000 and 100,000 layers of flakes.
5. 5. The reduced graphene oxide (rGO) film of claim 1 having a carbon to oxygen ratio of 0.8 to 2.0 as measured by X-ray photoelectron spectroscopy (XPS).
6. 6. The reduced graphene oxide (rGO) film according to any one of claims 1 to 5, which exhibits an X-ray diffraction spectrum in which a peak at 11±0.5, σ=4, 2 theta degrees is substantially absent as measured by an X-ray diffractometer using CuKα radiation (1.540598 Å), which is characteristic of non-reduced graphene oxide (wherein substantially absent means that the area / area % of the peak at 11±0.5 is about 1% or less).
7. 7. The reduced graphene oxide (rGO) film of claim 6, which exhibits a peak at 23±0.5, σ=4, 2 theta degrees in the X-ray diffraction spectrum measured by an X-ray diffractometer using CuKα radiation (1.540598 Å).
8. the rGO film has a top surface and the top portion, the top surface of the rGO film having an area of 25×25 μm as measured by atomic force microscope (AFM); 2 8. The reduced graphene oxide (rGO) film of claim 1 having a root mean square roughness of 1 to 200 nm for an area of 1 to 200 nm.
9. 20×20 μm 2 9. The reduced graphene oxide (rGO) film of claim 1 , wherein the film exhibits a D to G ratio of 0.9 or greater in a Raman spectrum for an area of 100 nm to 100 nm.
10. 10. The reduced graphene oxide (rGO) film of claim 1, exhibiting a resistivity of about 0.01 to 10 Ω cm.
11. 11. The reduced graphene oxide (rGO) film of any one of claims 1 to 10, wherein the elemental composition consists essentially of carbon in an amount of about 80% or more of the atomic composition and oxygen in an amount of about 20% or less of the atomic composition.
12. 2 to 10 mC / cm at a frequency of 1 kHz in an electrolyte-based system when implemented on electrodes with a diameter of approximately 25 micrometers 2 12. The reduced graphene oxide (rGO) film of claim 1 , capable of providing a charge injection limit (CIL) of 0.1 μm and / or an impedance of 10 to 100 kΩ.
13. 10 8 From 10 10 m -1 13. The reduced graphene oxide (rGO) film of claim 1, having a surface area to volume ratio (SAVR) of
14. 14. An electrically back-contacted conductive reduced graphene oxide (rGO) structure comprising the reduced graphene oxide (rGO) film of any one of claims 1 to 13 and an additional conductive support on which the rGO film is deposited, where back-contact means that the rGO film is placed on the additional conductive support such that a lower surface of the rGO film is in contact with one surface of the conductive support.
15. 15. The electrically back-contacted conductive structure of claim 14, wherein the additional conductive support is selected from the group consisting of metal, single layer graphene (SLG), few layer graphene (FLG), and multi-layer graphene (MLG).
16. A method for producing a reduced graphene oxide (rGO) film comprising a stack of reduced graphene oxide (rGO) layers containing flakes, the stack having a total film thickness of 20 nm to 5 micrometers and a distance between two consecutive layers of 0.2 to 0.7 nm, comprising: i) filtering a graphene oxide (GO) solution through a porous membrane, thereby forming a GO membrane on top of the porous membrane, wherein the graphene oxide (GO) solution is an aqueous solution, the concentration of graphene oxide (GO) in the solution is 0.001 to 5 mg / mL, and the volume to be filtered is 5 to 1000 mL; ii) transferring the GO film from the porous membrane onto a sacrificial substrate, the GO film being disposed between the upper porous membrane and the lower sacrificial substrate; iii) removing the film, thereby leaving the GO film attached on the sacrificial substrate; and iv) at a temperature of 100 to 240° C. for 10 5 From 4 x 10 8 hydrothermally reducing the GO film in the presence of water at a pressure of 1 Pa for a period of 1 min to 24 h to form a reduced graphene oxide (rGO) material; v) removing the rGO material from the sacrificial substrate; and A method for producing a reduced graphene oxide (rGO) film, comprising:
17. A method for producing an electrically back-contact conductive reduced graphene oxide (rGO) structure comprising a reduced graphene oxide (rGO) film comprising a stack of reduced graphene oxide (rGO) layers comprising flakes, the total film thickness being between 20 nm and 5 micrometers, with a distance between two successive layers being between 0.2 and 0.7 nm, and an additional conductive support on which the rGO film is deposited, comprising: By back contact is meant that the rGO film is placed on the additional conductive support such that the lower surface of the rGO film is in contact with one surface of the conductive support; i) filtering a graphene oxide (GO) solution through a porous membrane, thereby forming a GO membrane on top of the porous membrane, wherein the graphene oxide (GO) solution is an aqueous solution, the concentration of graphene oxide (GO) in the solution is 0.001 to 5 mg / mL, and the volume to be filtered is 5 to 1000 mL; ii') transferring the GO film from the porous membrane onto the additional conductive support, the GO film being disposed between the upper porous membrane and the lower additional conductive layer; iii') removing the film, whereby the GO film remains attached to the additional conductive support; and iv') at a temperature of 100 to 240°C, 5 From 4 x 10 8 hydrothermally reducing the GO film in the presence of water at a pressure of 1 Pa for a period of 1 min to 24 h to form a reduced graphene oxide (rGO) material; A method for producing a conductive reduced graphene oxide (rGO) structure, comprising:
18. 18. The method of any one of claims 16 to 17, wherein the hydrothermal reduction is carried out in a closed vessel inside an autoclave and the GO membrane is not in direct contact with water.
19. 16. An electronic device for detecting, receiving and / or guiding an electrical signal comprising a reduced graphene oxide (rGO) film according to any one of claims 1 to 13 or an electrically back-contacting conductive reduced graphene oxide (rGO) structure according to any one of claims 14 to 15.
20. 20. The electronic device of claim 19 which is a neural electrode.
21. 21. The electronic device of claim 19, comprising a flexible substrate patterned with conductive leads deposited on the rGO film or the electrically back-contacting conductive rGO structure, and an encapsulation layer having an opening thereon.
Citation Information
Patent Citations
Electrode, storage battery, power storage device, and electronic apparatus
JP2017027935A
Graphene membrane film for solvent purification, method for producing the same, and solvent purification system using the same
JP2018506418A
Cellular graphene membrane
JP2019507081A
Method for preparing microstructure arrays on the surface of thin film material
WO2017021936A1
